Psychedelic-Assisted Therapy in North Vancouver

Psychedelic-assisted therapy combines the intentional use of psychedelic substances with psychotherapy, preparation, and integration. Rather than viewing the psychedelic experience as a treatment in isolation, this approach uses altered states of consciousness within a carefully supported therapeutic process. Psychedelics can temporarily shift the way we experience ourselves, our emotions, our memories, and the world around us. For some people, this may create opportunities to access experiences, emotions, beliefs, or patterns that have been difficult to reach through conventional talk therapy alone.

But psychedelics alone do not heal people. The therapeutic potential of psychedelic-assisted therapy lies not only in the psychedelic experience itself, but in the work that surrounds it. Thoughtful preparation helps create a foundation for the experience, therapeutic support provides safety and containment during the process, and integration helps translate what emerges into meaningful change. The psychedelic experience may open a door, but the work of healing often involves what we do with what we discover.

At Conscious Mind Clinic in North Vancouver, BC, we approach psychedelic-assisted therapy as a process rather than a single event. Our work is trauma-informed, individualized, and grounded in respect for each person's history, nervous system, internal resources, and capacity for change. We support eligible individuals exploring MDMA-assisted therapy and psilocybin-assisted therapy through legal and authorized pathways in Canada, as well as individuals seeking psychedelic preparation and integration therapy.

You May Be Here Because...

You may be considering psychedelic-assisted therapy because you feel stuck in patterns that have been difficult to shift, despite significant insight or previous therapeutic work. Perhaps you understand intellectually why you feel or behave a certain way, but that understanding hasn't translated into meaningful change. You may recognize the origins of your anxiety, depression, trauma responses, relationship patterns, or self-protective behaviours, yet still find yourself returning to familiar ways of coping.

Some people explore psychedelic-assisted therapy after years of conventional treatment. Others are drawn to it because they want to understand themselves more deeply, reconnect with emotions or parts of themselves that feel inaccessible, or explore longstanding patterns from a different perspective. Whatever brings you here, psychedelic-assisted therapy is not about forcing a breakthrough or chasing a particular experience. It is about creating the conditions for curiosity, openness, and exploration within a process that prioritizes preparation, safety, and therapeutic support.

What Is Psychedelic-Assisted Therapy?

Psychedelic-assisted therapy is a therapeutic approach in which a psychedelic substance is used within a structured process that includes psychological support before, during, and after the psychedelic experience. Depending on the substance, psychedelic experiences may involve changes in perception, emotional awareness, memory, bodily sensations, sense of self, and patterns of thought. These altered states may allow people to relate differently to experiences that ordinarily feel overwhelming, inaccessible, or rigidly held.

In some cases, people may encounter difficult memories or emotions. In others, the experience may involve feelings of connection, compassion, grief, insight, or a significant shift in perspective. Experiences vary considerably from person to person, and there is no single type of psychedelic experience that is necessary for therapeutic change. The role of therapy is not to determine what you should experience, but to create a foundation from which you can approach what emerges with greater support and then explore how, or whether, it holds meaning for your life.

How Does Psychedelic-Assisted Therapy Work?

Psychedelic-assisted therapy generally involves several interconnected stages: assessment, preparation, the psychedelic session itself, and integration. The psychedelic session is therefore one component of a broader therapeutic process rather than a standalone intervention.

Assessment

Before psychedelic-assisted therapy is considered, an assessment process helps determine whether the approach may be appropriate for you. This may include exploring your physical and mental health history, current medications, previous experiences with psychedelics, therapeutic goals, support system, and other factors that may affect safety or eligibility. Psychedelic-assisted therapy is not appropriate for everyone, and careful screening is an important part of responsible and ethical care.

Preparation

Preparation provides an opportunity to build trust with your therapist, understand what to expect, explore your intentions, and develop resources for navigating the experience. It may also involve exploring fears, expectations, attachment patterns, trauma responses, and the ways you tend to respond when difficult emotions arise.

The purpose of preparation is not to control or predict the psychedelic experience. Instead, it is intended to help you develop a foundation of safety, curiosity, and flexibility from which to meet whatever may emerge. For individuals with histories of trauma, this stage can be particularly important in establishing trust, understanding protective responses, and developing ways to remain connected to the body and present moment when difficult material arises.

The Psychedelic Session

During a psychedelic-assisted therapy session, a psychedelic substance is administered in a controlled and supportive environment when legal access has been authorized and treatment is clinically appropriate. Sessions may last several hours depending on the substance being used. Throughout the experience, trained professionals remain present to provide support, monitor safety, and help maintain an environment in which the experience can unfold.

The role of the therapist is generally not to direct the content of the experience or determine where it should lead. Instead, the therapist provides a steady and supportive presence while helping you remain connected to your own internal process. What emerges may be emotional, physical, relational, symbolic, or difficult to put into words, and the experience itself can vary significantly between individuals and between sessions.

Integration

Integration is the process of exploring and making sense of what emerged during the psychedelic experience. Some experiences may feel immediately meaningful, while others may be confusing, emotionally complex, or difficult to understand. Insights that feel profound during an altered state do not automatically translate into lasting changes in everyday life.

Integration therapy provides space to reflect on the experience, explore its personal meaning, and consider how it may relate to your relationships, behaviours, beliefs, emotional patterns, and daily life. The goal is not simply to understand what happened during the psychedelic experience, but to determine what, if anything, you want to carry forward and how those insights might become embodied through meaningful changes in the way you live and relate to yourself and others.

Ketamine-Assisted Therapy

Ketamine is a prescription medication that has been used in medical settings as an anesthetic for decades. At certain doses, ketamine can produce altered states of consciousness that may involve changes in perception, a sense of distance from habitual thoughts or patterns, shifts in emotional awareness, and changes in the experience of the body or sense of self.

Within a therapeutic context, these effects may create opportunities to approach difficult emotions, experiences, or longstanding patterns from a different perspective. Research has investigated ketamine in relation to depression and other mental health concerns, although the evidence and treatment approaches vary depending on the condition, method of administration, and clinical setting.

Ketamine is an authorized prescription drug in Canada, although the use of racemic ketamine for mental health conditions such as depression is considered off-label. Esketamine, a related medication sold under the brand name Spravato, is authorized by Health Canada for specific indications involving major depressive disorder and is subject to controlled distribution requirements.

Ketamine-assisted therapy combines the effects of ketamine with psychological support, preparation, and integration. Depending on the treatment model, ketamine may be prescribed and administered by an appropriately authorized healthcare provider, while psychotherapy is incorporated before, during, or after the experience.

Cannabis-Assisted Therapy

Cannabis-assisted therapy involves the intentional use of cannabis within a therapeutic context to support psychological and emotional exploration. Although cannabis is not considered a classical psychedelic, its effects can sometimes involve shifts in perception, emotional awareness, bodily sensation, and patterns of thought. For some individuals, these effects may support greater awareness of emotions, internal experiences, or somatic patterns that can be explored within therapy.

When cannabis is incorporated into a therapeutic process, the focus is not simply on the effects of cannabis itself, but on how the experience is approached and supported. Preparation may help establish intentions and resources for navigating the experience, while integration provides an opportunity to explore what emerged and consider how insights or experiences may relate to everyday life.

Cannabis is legal in Canada and can also be accessed for medical purposes under Canada's cannabis regulations. However, cannabis-assisted therapy is not itself a Health Canada-approved treatment indication. Cannabis affects individuals differently and may not be appropriate for everyone. Careful consideration of an individual's mental health history, physical health, medications, and potential risks is important when determining whether this approach may be appropriate.

MDMA-Assisted Therapy

MDMA is not considered a classical psychedelic, but it is commonly included within the broader field of psychedelic-assisted therapy. Its effects may include increased emotional openness, changes in fear processing, and feelings of interpersonal connection or trust. Within a carefully supported therapeutic context, these effects may help some individuals approach difficult emotions, memories, or traumatic experiences from a different perspective.

MDMA-assisted therapy has been studied extensively in relation to post-traumatic stress disorder (PTSD). In Canada, MDMA remains a controlled substance and is not generally available as a standard prescription treatment. Legal access is restricted and must occur through an authorized pathway, such as an approved clinical trial or, in eligible circumstances, through Health Canada's Special Access Program.

At Conscious Mind Clinic, we support eligible clients through psychedelic-assisted therapy involving MDMA when access has been legally authorized through an applicable pathway, treatment is clinically appropriate, and relevant regulatory requirements have been met.

Psilocybin-Assisted Therapy

Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms. It can produce significant changes in perception, emotion, cognition, and sense of self. Experiences may include shifts in perspective, increased emotional awareness, changes in one's relationship to longstanding thoughts or beliefs, and experiences of connection or meaning.

Research has investigated or continues to investigate psilocybin-assisted therapy in relation to depression, anxiety and existential distress associated with serious or life-limiting illness, substance use disorders, and other mental health concerns. The evidence varies depending on the condition being studied, and emerging research does not mean that psilocybin-assisted therapy is appropriate or effective for every individual.

In Canada, psilocybin remains a controlled substance. Legal access is restricted and must occur through an authorized pathway, such as an approved clinical trial or, in eligible circumstances, through Health Canada's Special Access Program. At Conscious Mind Clinic, we support eligible clients through psychedelic-assisted therapy involving psilocybin when access has been legally authorized, treatment is clinically appropriate, and relevant regulatory requirements have been met.

What Is Psychedelic-Assisted Therapy Being Studied For?

Research and clinical trials have investigated or are continuing to investigate psychedelic-assisted approaches for a range of mental health concerns, including post-traumatic stress disorder (PTSD), depression, anxiety and distress associated with serious or life-limiting illness, substance use disorders, obsessive-compulsive disorder (OCD), and eating disorders.

The strength and maturity of the evidence differs considerably depending on the psychedelic substance and the condition being treated. Psychedelic-assisted therapy should not be understood as an established treatment for every condition currently being studied, and research findings at a group level cannot determine whether this approach will be appropriate or effective for a particular individual.

Why Use Psychedelics in Therapy?

Researchers are continuing to investigate the mechanisms that may contribute to therapeutic outcomes associated with psychedelic-assisted therapy. Depending on the substance, research has explored potential changes in emotional processing, fear responses, cognitive flexibility, neuroplasticity, and patterns of brain activity associated with self-referential thinking.

From a therapeutic perspective, altered states may temporarily change the way a person relates to their thoughts, emotions, memories, and sense of self. Experiences that ordinarily feel too threatening or difficult to approach may sometimes be encountered with greater openness or from a different perspective. This may create opportunities to explore deeply held beliefs, emotional wounds, traumatic experiences, or longstanding patterns in ways that feel different from ordinary states of consciousness.

However, an altered state is not inherently therapeutic. The context in which the experience occurs, the person's readiness and psychological history, the quality of preparation and support, and the work of integration afterward can all influence the therapeutic process.

Is Psychedelic-Assisted Therapy Legal in Canada?

The legal status of psychedelic-assisted therapy in Canada depends on the substance being used.

MDMA and psilocybin are controlled substances and are not generally available as standard prescription treatments. One potential pathway for legal access is Health Canada's Special Access Program (SAP), which allows health and dental practitioners to request access to drugs that are not available for sale in Canada for patients with serious or life-threatening conditions when conventional treatments have failed, are unsuitable, or are unavailable in Canada. Each request is assessed individually by Health Canada, and authorization is not guaranteed.

MDMA and psilocybin may also be legally accessed in certain authorized clinical trials or through other applicable exemptions or pathways under Canadian law.

Ketamine has a different regulatory status. It is an authorized prescription drug in Canada, although the use of racemic ketamine for mental health conditions such as depression is considered off-label. Esketamine is authorized by Health Canada for specific indications involving major depressive disorder.

Cannabis is legal in Canada and can be accessed through Canada's non-medical and medical cannabis frameworks. Cannabis-assisted therapy, however, is not itself a Health Canada-approved treatment indication.

Because the legal and regulatory requirements differ depending on the substance and may change over time, the appropriate pathway must be considered based on the treatment being explored and an individual's circumstances.

Psychedelic-Assisted Therapy vs. Psychedelic Preparation and Integration

Psychedelic-assisted therapy and psychedelic preparation and integration are related services, but they are not the same.

Psychedelic-assisted therapy refers to a structured therapeutic process in which an altered-state or psychedelic session forms part of the treatment. The legal and clinical requirements depend on the substance involved. For controlled substances such as MDMA and psilocybin, access must occur through an applicable authorized pathway. Other substances, including ketamine and cannabis, are governed by different regulatory frameworks.

Psychedelic preparation and integration therapy can also be provided as a separate service. In this context, the therapist does not provide or administer a psychedelic substance. Instead, therapy focuses on helping individuals prepare psychologically for an experience or process and integrate an experience that has already occurred.

At Conscious Mind Clinic, we distinguish between psychedelic-assisted therapy involving a legally authorized substance and psychedelic preparation and integration provided as a standalone therapeutic service.

Risks and Considerations

Psychedelic-assisted therapy is not appropriate for everyone and is not without risk. Psychedelic experiences can be emotionally and psychologically intense, and difficult memories, fear, grief, confusion, or overwhelming emotions may emerge during or after an experience. Certain physical health conditions, psychiatric histories, and medications may also affect whether psychedelic-assisted therapy can be considered safely.

For these reasons, responsible psychedelic-assisted therapy requires careful screening, informed consent, appropriate preparation, qualified professional support, and attention to integration and follow-up care. Psychedelic-assisted therapy is not a quick fix, and no particular experience or therapeutic outcome can be guaranteed.

Our Approach to Psychedelic-Assisted Therapy

At Conscious Mind Clinic, we believe psychedelic-assisted therapy is about more than the psychedelic experience itself. Psychedelics alone do not heal people. We view the experience as one part of a broader therapeutic process that includes careful assessment, preparation, skilled support, and thoughtful integration.

Our approach is trauma-informed and grounded in an understanding that many of the patterns people hope to change developed for a reason. Anxiety, avoidance, emotional disconnection, hypervigilance, perfectionism, people-pleasing, and other protective strategies may have emerged as intelligent adaptations to earlier experiences and environments. The goal is not to use psychedelics to bypass these protective patterns or force them to disappear.

Instead, psychedelic-assisted therapy may create an opportunity to approach yourself and your experiences differently, with greater curiosity, compassion, and openness. Therapy provides a space to understand what emerges, work with it at a pace that respects your individual process, and support meaningful changes that can continue long after the psychedelic experience itself has ended.